JPRN-UMIN000023245已完成未知
Efficacy and safety of dulaglutide when used instead of sitagliptin in type 2 diabetic patients - Efficacy and safety of dulaglutide when used instead of sitagliptin in type 2 diabetic patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Type 1 diabetes 2. Patients with severe renal failure or liver dysfunction 3. Patients with drug allergy for ipraglifrozin 4. Patients with history of diabetec ketosis 5. Patients with shick day
研究者
相似试验
已完成
不适用
Efficacy and safety of dulaglutide when used instead of exenatide extended-release in type 2 diabetic patientsType 2 diabetes mellitusJPRN-UMIN000019031Haga Diabetes Clinic40
招募中
不适用
Efficacy and safety of dulaglutide in the treatment of type 2 diabetesType 2 diabetes mellitus patientsJPRN-UMIN000027255Department of nephrology, Matsunami general hospital30
已完成
不适用
Safety and efficacy of dulaglutide therapy for the inpatient management of general medicine patients with type 2 diabetesType 2 diabetesJPRN-UMIN000025006Ichinomiyanishi hospital40
未知
不适用
Comparison of the efficacy and safety of dulaglutide in combination with insulin compared with insulin alone in daibetes patients who are receiving high dose glucocorticoids therapy: a randomized,open-label trialDiabetes mellitusJPRN-UMIN000020037Kanagawa Cardiovascular and Respiratory Center30
已完成
不适用
Efficacy of dulaglutide after switching from incretin related drugs in patients with type 2 diabetestype 2 diabetesJPRN-UMIN000042812Edogawa Hospital101